Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong Efficacies with/without Oxaliplatin in an Animal Study for Colon Cancer
Date: Aug 21, 2018
Source: Therabiopharma Inc.
KAWASAKI, Japan – Therabiopharma, a Japan based bio-venture, reports that CMG(Curcumin Monoglucuronide) has proven:
Continue reading »